Kezdőlap・Részvénylista・AtriCure Inc

AtriCure Inc

Lezárt

SzektorEgészségügy

44.15 1.63

Vétel Eladás

Áttekintés

Árfolyamváltozás megosztása

24 óra

Jelenlegi

Minimum

42.67

Maximum

44.41

Fő mutatók
By Trading Economics
Bevétel	8.8M 9M
Értékesítés	12M 154M
P/E Szektor átlag	198.286 57.002
Egy részvényre jutó nyereség	0.18
Profit margin	5.83
Munkavállalók	1,350
EBITDA	-3.8M 3.2M

Ajánlások
By TipRanks
Ajánlások	Erős vétel
12 hónapos előrejelzés	+8.74% upside

Osztalékok
By Acuity
Következő eredményjelentés	2026. okt. 28.

Piaci statisztika
By TradingEconomics
Piaci kapitalizáció	357M 2.1B
Előző nyitás	42.52
Előző zárás	44.15

Hangulat hírek alapján

By Acuity

50%

163 / 340 Rangsor szerint Healthcare

AtriCure Inc Chart

A múltbeli teljesítmény nem megbízható mutatója a jövőbeli eredményeknek.

Kapcsolódó hírek

2026. aug. 12. 20:06 UTC

AtriCure Inc shares are higher today, continuing a nine-session streak of gains. The stock remains above its 20-day moving average.

2026. aug. 11. 22:41 UTC

AtriCure Inc shares are higher in after-market trading, continuing a recent trend of strength amid changing monetary policies from central banks.

2026. aug. 7. 20:03 UTC

AtriCure Inc's shares are higher during Friday's session, continuing an upward trend since Thursday's close, and remain above their 20-day moving average.

2026. aug. 6. 19:12 UTC

AtriCure Inc shares are higher, benefiting from an upward trend in the Health Care Equipment sub-sector. Earlier, the stock peaked before a slight pullback.

2026. aug. 5. 19:51 UTC

AtriCure Inc shares are higher today, despite no specific news. Broader market sentiment is cautious following ADP's disappointing employment report.

2026. aug. 3. 20:06 UTC

AtriCure Inc. shares are higher during Monday's session, regaining ground after an earlier pullback. Broader market trends support positive investor sentiment.

2026. júl. 31. 20:03 UTC

News

AtriCure shares are lower amid significant insider selling, including a $233,280 sale by Chief Scientific Officer Vinayak Doraiswamy and options exercised by Board Member Sven Wehrwein.

2026. júl. 30. 18:56 UTC

AtriCure Inc's shares are lower today, impacted by declines in the Health Care Equipment sub-sector. No specific company news was identified for the movement.

2026. júl. 29. 20:03 UTC

News

AtriCure Inc shares reached a 52-week high of $43.18 following better-than-expected quarterly earnings, despite a pullback earlier in the session.

2026. júl. 28. 19:21 UTC

AtriCure Inc's shares are higher today amid stronger gains in U.S. and European indices, with no specific company news identified for the movement.

2026. júl. 27. 20:02 UTC

News

AtriCure Inc shares are higher as the company prepares for two investor conferences and highlights CEO Michael Carrel's leadership appointment.

2026. júl. 24. 21:41 UTC

AtriCure Inc. shares traded roughly flat in after-market hours. The stock has performed well recently, positioned near the upper end of its monthly range.

2026. júl. 23. 21:51 UTC

News

AtriCure reported strong Q2 results and raised EPS guidance but shares fell in after-market trading, marking the sixth consecutive session of declines.

2026. júl. 22. 19:56 UTC

AtriCure Inc shares are trading lower, reaching a session low just before 15:30 ET, despite remaining above the 20-day moving average.

2026. júl. 21. 19:16 UTC

AtriCure Inc shares are trading lower today, continuing a trend of declines over the past three sessions, despite gains in the Nasdaq 100 Index.

2026. júl. 20. 19:51 UTC

AtriCure Inc continues higher today, maintaining strength since Friday's close, despite a recent pullback earlier in the session.

Társak összehasonlítása

Árváltozás

AtriCure Inc Előrejelzés

Célár

By TipRanks

8.74% elmozdulás felfelé

12 hónapos előrejelzés

Átlag 47.29 USD 8.74%

Magas 55 USD

Alacsony 36 USD

8 Wall Street elemző 12 hónapos célárain alapulva a(z)AtriCure Inc termékhez az elmúlt 3 hónapban.

Értékelési konszenzus

By TipRanks

Erős vétel

8 ratings

Vétel

Tartás

Eladás

8 Wall Street elemző célárain alapulva a(z)AtriCure Inc termékhez az elmúlt 3 hónapban.

Hangulat

By Acuity

163 / 340 Rangsor szerint Egészségügy

Pénzügyek

Értékesítési és adminisztrációs költségek

Üzemeltetési költségek

Adózás előtti nyereség

Értékesítés

Értékesítési költség

Értékesítési bruttó nyereség

Kamatköltség a hitelre

EBITDA

Üzemi nyereség

Rólunk AtriCure Inc

AtriCure, Inc. develops, manufactures, and sells devices for surgical ablation of cardiac tissue, exclusion of the left atrial appendage, and temporarily blocking pain by ablating peripheral nerves to medical centers in the United States, Europe, the Asia-Pacific, and internationally. The company offers Isolator Synergy Clamps, single-use disposable radio frequency products; multifunctional pens and linear ablation devices, such as the MAX Pen device that enables surgeons to evaluate cardiac arrhythmias, perform temporary cardiac pacing, sensing, and stimulation, and ablate cardiac tissue with the same device; and the Coolrail device, which enables users to make longer linear lines of ablation. It also provides cryoICE Cryoablation System that enables the user to make linear ablations of varied lengths; EPi-Sense Systems, a single-use disposable device used for the treatment of symptomatic, drug-refractory, and long-standing persistent atrial fibrillation; cryoSPHERE probe, which provides temporary pain relief by applying cryothermic energy to targeted intercoastal peripheral nerves in the ribcage; AtriClip System, an implantable device coupled to a single-use disposable applier; and LARIAT System, a suture-based solution for soft-tissue closure. In addition, the company sells Lumitip dissectors to separate tissues to provide access to key anatomical structures that are targeted for ablation; Glidepath guides for placement of clamps; Subtle Cannula's to support access for EPi-Sense catheters; and various reusable cardiac surgery instruments. It markets and sells its products through independent distributors and direct sales personnel. The company was incorporated in 2000 and is headquartered in Mason, Ohio.